Martin Eastgate
About Martin Eastgate
Martin Eastgate is the Executive Director at Bristol-Myers Squibb and serves in various advisory and board roles at multiple organizations, including NATA, ORGANIC REACTIONS INC, and the Royal Society of Chemistry.
Executive Director at Bristol-Myers Squibb
Martin Eastgate holds the title of Executive Director at Bristol-Myers Squibb. In this role, he is involved in the development of disruptively innovative science. He has managed teams both in the US and internationally, contributing significantly to the delivery of Bristol-Myers Squibb's portfolio.
Reviewer for Nucleic Acid Therapy Accelerator (NATA)
Since January 2021, Martin Eastgate has been serving as a Reviewer for the Nucleic Acid Therapy Accelerator (NATA). His responsibilities include reviewing proposals, ensuring high standards of scientific research, and advancing nucleic acid therapies.
Board of Directors Member at ORGANIC REACTIONS INC
Martin Eastgate is an active member of the Board of Directors at ORGANIC REACTIONS INC. His role involves governance, strategic planning, and oversight responsibilities contributing to the organization's leadership and direction.
Editorial Advisory Board at Organic Process Research and Development, ACS
Martin Eastgate is on the Editorial Advisory Board of Organic Process Research and Development, a journal under the American Chemical Society (ACS). His contributions encompass guiding editorial policies and reviewing scientific manuscripts to uphold the journal's standards of innovative research.
Fellow of the Royal Society of Chemistry (FRSC)
Martin Eastgate has achieved the status of Fellow of the Royal Society of Chemistry (FRSC). This recognition reflects his significant contributions to the chemical sciences and his involvement with the global chemistry community.
Scientific Advisory Board at Asymchem Group
Martin Eastgate is a member of the Scientific Advisory Board at Asymchem Group. In this capacity, he provides expert guidance on scientific matters, influencing research directions and scientific strategies within the organization.